Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke
Penumbra received FDA clearance for THUNDERBOLT, the first Computer Assisted Vacuum Thrombectomy (CAVT) platform designed to address acute ischemic stroke by enabling faster, more complete clot removal. The technology leverages the Penumbra ENGINE to deliver modulated aspiration, a mechanism intended to minimize catheter manipulation and safely ingest clot at the site of occlusion.
Key figures
- Drug Name
- THUNDERBOLT
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.